The next phase for the study is to determine if people who have been exposed to COVID-19 and are given plasma can build immunity to disease.
600 thousand and to help those infected, mayo clinic doctors and other health officials conducted a three month long study, finding covid?
"* 19 patients transfused with convalescent plasma, which contains high levels of antibodies, are showing a greater survival rate.
Kimt news 3's madelyne watkins joins us live this morning to break down this clinical study even more for us, madelyne?/// brooke and tyler.
First off... if you're not familiar with convalescent plasma... it's the part of your blood that's collected when you recover from covid?
"*19.
Over 35 thousand hospitalized patients with the virus... who were transfused with convalescent plasma ?
"(?
"(within 3 days of diagnosis?
"(?
"( were associat with a greater survival rate?
*- the study shows.
It's important to mention again that this type of plasma has high levels of antibodies to fight covid?
"* 19.
The higher amount of antibodies... means there's a better chance for you to survive.
Doctor michael joyner explains what the next steps are in this "we need to continue to look at our database and continue to try and understand what properties in convalescent plasma are associated with improved outcomes.
The volume convalescent plasma requires, or does it make a difference?
How much do we need to give?"
Doctor joyner says moving forward... they're going to determine if people who have been exposed to covid?
"*19 and are given convalescent plasma can build immunity to the disease.
Live in rochester.
Madelyne watkins kimt thank you madelyne.
Mayo clinic wants to make it known that this study was not intended to be a clinical trial to determine the effectiveness of convalescent plasma... but rather to increase access to plasma with the intent of helping
Despite promising results surrounding convalescent plasma as a Covid-19 treatment, the FDA says it needs more data before it issues..